Granules India Limited

NSE GRANULES.NS

Granules India Limited Operating Cash Flow for the year ending March 31, 2024: USD 52.68 M

Granules India Limited Operating Cash Flow is USD 52.68 M for the year ending March 31, 2024, a -34.76% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Granules India Limited Operating Cash Flow for the year ending March 31, 2023 was USD 80.75 M, a 84.65% change year over year.
Granules India Limited Operating Cash Flow for the year ending March 31, 2022 was USD 43.73 M, a -25.96% change year over year.
Granules India Limited Operating Cash Flow for the year ending March 31, 2021 was USD 59.06 M, a -6.53% change year over year.
Granules India Limited Operating Cash Flow for the year ending March 31, 2020 was USD 63.19 M, a 67.45% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

NSE: GRANULES.NS

Granules India Limited

CEO	Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.
IPO Date	June 20, 2005
Location	India
Headquarters	My Home Hub
Employees	4,057
Sector	Health Care
Industries Pharmaceuticals

Description

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Key trends

Past 5 years